India’s pharmaceutical industry witnessed a growth of 9.43% CAGR in the past nine years. India is the largest provider of generic drugs worldwide. Here are the best pharma stocks in India.
Pfizer has a vast portfolio of vaccines, cardiac medications, nutrition supplements, and other drugs. The company exports products to over 50 countries. Analyst Rating: 100 Market cap as of 23-12-2024: ₹21,350 crore
Fortis Healthcare is one of the largest healthcare organisations in India and has over 400 diagnostics centres across India. Analyst Rating: 91 Market cap as of 23-12-2024: ₹51,126 crore
Sun Pharma is the fourth-largest specialty generic pharmaceutical company in the world. It supplies products to over 100 countries. Analyst Rating: 89 Market cap as of 23-12-2024: ₹4,33,920 crore
Ajanta Pharma’s business includes manufacturing of finished formulas and also active pharmaceutical ingredients (APIs). It supplies branded generic drugs to several countries. Analyst Rating: 85 Market cap as of 23-12-2024: ₹35,621 crore
Abbott India’s portfolio includes multi-specialty drugs, vitamins, and treatments for various conditions. The company also offers vaccines for typhoid, influenza, and diarrhoea. Analyst Rating: 83 Market cap as of 23-12-2024: ₹60,855 crore
Swipe up to read a detailed analysis of the Best Pharma Stocks in India
Scroll up to get an overview of our RA Disclaimer and Stocks Selection Criteria.
Open a Groww Account & start investing!